Author:
Borra Vamsikalyan,Mahadevan Arankesh,Gautam Senapati Sidhartha,Vempati Roopeessh,Jaiswal Vikash,Borra Nithya,Ahmad Javaria,Rodrigo Zamudio Herrera Oscar,Vergara Sanchez Carlos,Prasad Tanisha,Thachil Rosy,Ganatra Sarju,Dani Sourbha
Reference43 articles.
1. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm [Internet]. 2017 [cited 2024 Feb 3];14:e275–e444. Available from: https://www.sciencedirect.com/science/article/pii/S1547527117305908.
2. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology;Joglar;Am. Heart Assoc. Joint Committee Clin. Pract. Guidel. Circulat.,2024
3. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis;Ganesan;J. Am. Heart Assoc.,2013
4. Ablation versus antiarrhythmic drugs as first-line therapy for treatment-naive atrial fibrillation: a systematic review and meta-analysis;Ullah;Am. J. Cardiol.,2023
5. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study);Mont;Eur. Heart J.,2014